Is Your Capital Following a Real Strategy?

Trade with $100K-$200K funded capital-no manual trading. Our AI system skips charts, eliminates stress, and lands you funding. Thousands passed prop challenges with us. Apply now, book a call, and have $10K ready.

IQV
IQVIA Holdings Inc
NYSE
180
Open 178.51 Prev Close 178.95
High 180.80 Low 178.51
Volume 21 Volume (Avg) 2,424
52 Week High 252.88 52 Week Low 134.65
Market Cap 30.6B PE Ratio 26.07

Shares Stats

Shares Outstanding170,000,000
Shares Float168,530,000
Shares Short9,050,000
Insider Holdings105%
Institution Holdings98.36%

About IQVIA Holdings Inc

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. It has a strategic collaboration with Sarah Cannon Research Institute to enhance clinical trial processes. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is based in Durham, North Carolina.

General

NameIQVIA Holdings Inc
TickerIQV
ExchangeNYSE
SectorHealthcare
IndustryDiagnostics & Research
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees90,000

Highlights

Analyst Target212.79
Market Cap30,600,000,000
PE Ratio26.07
PEG Ratio1.02
EBITDA2,923,000,064

Financials

Curr Year EPS Estimate11.87
Next Quarter EPS Estimate3.05
Profit Margin7.88%
Operating Margin14.40
Return on Assets0.05
Return on Equity0.20
Revenue15.7B
Earnings Per Share6.96
Revenue Per Share88.63
Gross Profit5,376,999,936
Quarterly Revenue Growth0.05

Valuation

Trailing PE25.71
Forward PE15.06
Price/Sales (Trailing 12 Mt.)1.94
Price/Book (Most Recent Quarter)5.22

Earnings

Most Popular

Eric Trump Teases American Bitcoin Stock Market Listing: 'Next Stop NASDAQ'

Eric Trump announced on Wednesday that American Bitcoin (ABTC) is set to make its debut on NASDAQ. This announcement was made via X, signaling a significant milestone for the Trump family-backed Bitcoin mining firm.

How India ended up facing steep US tariffs despite its strategic partnership

NEW DELHI (AP) — U.S. President Donald Trump has vowed for its purchases of , bringing the combined tariffs imposed by the United States on to 50%. India has called the additional tariffs “unfortunate.”

The Surprising New Date That Could Fuel the AI Boom - Ad

Trump's economic blueprint is about to go live, and the deadline is fast-approaching. A new federal plan could legally unlock $100 trillion in U.S. resources... and one $10 stock could lead the charge. Former hedge fund manager Whitney Tilson explains how to act now, before this hits the headlines.

Paula Deen has abruptly closed the Savannah restaurant that launched her to Food Network fame

SAVANNAH, Ga. (AP) — Former Food Network star Paula Deen announced Friday the abrupt closure of the Savannah restaurant that launched her to fame with its menu of fried chicken, banana pudding and other indulgent Southern dishes.

Weiss Gold Veteran Makes Shocking New Call - Ad

Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.

Texas AG claimed three homes as primary residence. Democrats are being probed for similar issue

WASHINGTON (AP) — Texas Attorney General Ken Paxton and his wife, Angela, are longtime owners of a $1.5 million house in a gated community outside Dallas. In 2015, they snapped up a second home in Austin. Then another.

Coldplay's jumbotron captures — what exactly? The internet has its theories

LONDON (AP) — It started out as a routine bit of fun at a Coldplay concert: Lead singer Chris Martin asked the cameras to scan the crowd for his “Jumbotron Song,” when he sings a few lines about the people the camera lands on.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

Tap Into the $65B 'Shroom Boom' - Ad

People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.

Is Costco Stock Topping Out? Key Price Levels To Watch

Costco stock (COST) may have formed a long-term peak. Adhishthana Principles suggest the next move could define the stock's future trajectory.

Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad

Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.

TransMedics Group Stock Jumps On Q2 Earnings Beat, Company Raises 2025 Outlook

TransMedics Group shares are rising in Wednesday's after-hours session after the company reported financial results for the second quarter.

Tim Walz: Trump 'Brings Out the Worst in Me'

Gov. Tim Walz (D-Minn.) offered a candid reflection on his rhetoric toward Donald Trump, acknowledging regret over earlier inflammatory comments made during the 2024 presidential campaign.

Better Than Bitcoin? (Top Crypto for Less Than $1) - Ad

Over the past 15 years, Bitcoin has outperformed stocks, bonds, and every other asset you could've bought. 2025 is already shaping up to be another banner year, with Bitcoin recently hitting a new all-time high. But there's a better way to profit from this new crypto rally. Most people don't know about it... and yet it's returned over 1,000% in 4 months. This could be the #1 way to invest in crypto right now.

Verizon Beats Expectations, Boosts Outlook — Here's Why Analysts Still See More Room To Grow

Verizon's Q2 results beat expectations, driven by wireless and broadband offerings. Analysts raised price targets, but net additions were lower.

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

EU and Japan agree to work together to promote free trade and economic security

TOKYO (AP) — Leaders of the and Japan launched an alliance Wednesday aimed at boosting economic cooperation, defending free trade and countering unfair trade practices as the two sides face growing challenges from the United States and China.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Education Department says it will release billions in remaining withheld grant money for schools

WASHINGTON (AP) — The Trump administration is releasing billions of dollars in grants to schools for adult literacy, English language instruction and other programs, the Education Department said Friday.

Stellantis warns of $2.7 billion loss for 1st half of 2025 due to tariffs and some big charges

Stellantis, the maker of Jeep and Ram vehicles, says its preliminary estimates show a 2.3 billion euros ($2.68 billion) net loss in the first half of the year due to U.S. tariffs and some hefty charges.

Trading Isn't Your Job. Let the System Handle It. - Ad

HiveMind AI handles trades for you-based on logic, not gut instinct. Built by pro traders. Runs 24/7. No emotions. No second-guessing. Want to deploy capital smarter?

Anthropic Study Shows AI Chatbots Can Transfer Their Bad Habits Through Hidden Signals In Data

AI systems can pick up hidden biases from data, leading to safety concerns. Study shows this can happen even with small models sharing architecture.

Is Your Capital Following a Real Strategy? - Ad

Trade with $100K-$200K funded capital-no manual trading. Our AI system skips charts, eliminates stress, and lands you funding. Thousands passed prop challenges with us. Apply now, book a call, and have $10K ready.

Samsung Electronics Shares Fall 2.54% Following Tesla's $16.5 Billion AI Chip Manufacturing Agreement

Samsung Electronics Co. Ltd. shares declined 2.54% following Tesla Inc.'s confirmation of a $16.5 billion chip manufacturing partnership.

How Palantir, Tempus, Nvidia-Backed Recursion Are Disrupting Big Pharma

AI-native players like Palantir, Tempus, and Recursion are disrupting drug discovery and attracting investors, while Big Pharma struggles.

The Surprising New Date That Could Fuel the AI Boom - Ad

Trump's economic blueprint is about to go live, and the deadline is fast-approaching. A new federal plan could legally unlock $100 trillion in U.S. resources... and one $10 stock could lead the charge. Former hedge fund manager Whitney Tilson explains how to act now, before this hits the headlines.

Weiss Gold Veteran Makes Shocking New Call - Ad

Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.

Takeaways from the AP's reporting on Trump's business deals

WASHINGTON (AP) — From crypto coins to overseas development deals to an upcoming line of cellphones, President Donald Trump's family businesses have raked in hundreds of millions of dollars since his election.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

Japanese leader Ishiba vows to remain despite speculation, says he will focus on new US trade deal

TOKYO (AP) — Prime Minister on Wednesday vowed to remain in power to oversee the implementation of a , despite media speculation and growing calls for him to resign after a .

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright traderelite.club
Privacy Policy | Terms of Service